Behçet s disease (BD) is a chronic inflammatory disorder
|
|
- Calvin Sutton
- 5 years ago
- Views:
Transcription
1 Association of MICA Gene and HLA-B*5101 with Behçet s Disease in Greece Kazuro Yabuki, 1,2 Nobuhisa Mizuki, 1,2 Masao Ota, 3 Yoshihiko Katsuyama, 3 Gerasimos Palimeris, 4 Caterina Stavropoulos, 5 Yvonni Koumantaki, 4 Marylin Spyropoulou, 5 Ernestini Giziaki, 4 Virginia Kaklamani, 6 Evangelia Kaklamani, 4 Hidetoshi Inoko, 2 and Shigeaki Ohno 1 PURPOSE. Behçet s disease (BD) is known to be associated with HLA-B51 in many different ethnic groups. Recently MICA, a member of a novel family of the human major histocompatibility complex (MHC) class I genes termed MIC (MHC class I chain-related genes), was identified near the HLA-B gene, and a triplet repeat microsatellite polymorphism was found in the transmembrane (TM) region. Because a strong association with BD of one particular MICA-TM allele, A6, was shown in a Japanese population, the present study was conducted to investigate microsatellite polymorphism in Greek patients with BD to know whether this association is generally observed in BD occurring in other populations. METHODS. Thirty-eight Greek patients with BD and 40 ethnically matched control subjects were examined for MICA microsatellite polymorphism using polymerase chain reaction (PCR) and subsequent automated fragment detection by fluorescent-based technology. RESULTS. Similar to the Japanese patients with BD, the phenotype frequency of the MICA-TM A6 allele was significantly increased in the Greek patients with BD (50.0% in control subjects versus 86.8% in BD cases), with an odds ratio (OR) of 6.60 (P ). The MICA-A6 allele was found in a high frequency both in males and females (weighted OR 6.68; P ). No association was found between the A6 allele and several disease features. A strong association exists between the MICA-TM A6 allele and the B*5101 allele in both the control subjects and patients with BD (weighted OR 44.39; P ). CONCLUSIONS. This study revealed in Greek patients a strong association of BD with a particular MICA-TM allele, MICA-A6, providing insight into the molecular mechanism underlying the development of BD. (Invest Ophthalmol Vis Sci. 1999;40: ) Behçet s disease (BD) is a chronic inflammatory disorder with recurrent oral and genital ulcers, uveitis, and vasculitis, along with mucocutaneous, arthritic, and neurologic manifestations. 1 It exists worldwide but is found in a higher prevalence in Japan, China, and Korea and along the Silk Route to the countries of the Mediterranean. 2 We and others have presented evidence for an HLA association with BD, and From the 1 Department of Ophthalmology, Yokohama City University School of Medicine; the 2 Department of Genetic Information, Division of Molecular Life Science, Tokai University School of Medicine, Kanagawa; and the 3 Department of Legal Medicine, Shinshu University School of Medicine, Nagano, Japan; the 4 Department of Hygiene and Epidemiology, University of Athens Medical School; the 5 National Tissue Typing Center, George Gennimatas General Hospital, Athens, Greece; and the 6 Newton Wellesley Hospital, Department of Internal Medicine, Boston, Massachusetts. Supported by Grants-in-Aid and from the Ministry of Education, Science, Sports and Culture, Japan; a grant from the Ministry of Health and Welfare, Japan; and a research grant from Kanagawa Academy of Science and Technology. Submitted for publication November 24, 1998; revised February 22, 1999; accepted March 10, Proprietary interest category: N. Reprint requests: Shigeaki Ohno, Department of Ophthalmology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawaku, Yokohama, Kanagawa , Japan. HLA-B51 (HLA-B*51 at the DNA typing-defined allele level) was found to be the most strongly associated genetic marker in these populations. 2 6 However, it has not yet been clarified whether the HLA-B51 gene itself is the pathogenic gene related to BD or whether it is some other gene in linkage disequilibrium with HLA-B51. Although the cause and pathogenesis of BD are still uncertain, the onset of BD is believed to be triggered by the involvement of some external environmental factors in people with a particular genetic background. The mean age at onset is the third decade, children are rarely affected, and few neonatal cases have been reported. The main microscopic finding at most sites of active BD is immune-mediated occlusive vasculitis. At the cellular level, CD4 T cells are found in the perivascular inflammatory exudates, and Th1 cells respond to various stimuli to produce interleukin (IL)-2, interferon (IFN)-, and tumor necrosis factor- (TNF ). 7 In the recent studies, an increased number of T cells in the peripheral blood and the involved tissues, and the phenotypically distinct subset of T cells at the sites of inflammation were reported Furthermore, significant T-cell proliferative responses to mycobacterial 65-kDa heat shock protein peptides and their homologous peptides derived from the human 60-kDa heat shock protein were observed in patients with BD. 11,12 Therefore, BD is probably not a simple hereditary disease, and the onset of the Investigative Ophthalmology & Visual Science, August 1999, Vol. 40, No. 9 Copyright Association for Research in Vision and Ophthalmology 1921
2 1922 Yabuki et al. IOVS, August 1999, Vol. 40, No. 9 disease may be triggered by some exogenous antigen(s) such as bacteria, virus, or some microorganism. Recently, a highly divergent MHC class I chain-related gene family, MIC, was identified within the class I region. 13 Among the five MIC genes so far identified, two genes, MICA and MICB, are functional genes and are located between the HLA-B and TNF genes. The MICA gene located only 46-kb centromeric of HLA-B 14 is a highly polymorphic member of this family and is mainly expressed in epithelial cells, keratinocytes and monocytes 15,16 in contrast to MHC class I genes, which are almost ubiquitously expressed. The characteristics include the absence of association with 2 -microglobulin ( 2 M), stable expression without conventional class I peptide ligands, and the absence of a CD8 binding site. 16,17 Expression of MICA is not affected by type I and II interferons, 16,17 known to upregulate markedly the level of typical MHC class I gene expression. However, notably, the 5 -end flanking region of the gene for MICA includes putative heat shock elements similar to those of HSP70 genes, and MICA mrnas are augmented in heat shock stressed epithelial cells. 16,17 In the recent study, MICA molecule was found to be recognized by particular T cells expressing diverse V 1 T-cell receptors extracted from intestinal epithelium tumors. 18 It is suggested that MICA molecule may play an important role as a selfantigen, stress-induced, and may broadly regulate protective responses by V 1 T cells in the epithelium. 18 During nucleotide sequence analysis of the transmembrane (TM) region of the MICA gene, we found a triplet repeat microsatellite polymorphism of GCT (alanine). 19 Microsatellite polymorphism was investigated in Japanese patients with BD, and a strong association of six GCT repetitions (MICA-A6 allele) with BD was found. Thus, the MICA gene was considered a strong candidate gene controlling the susceptibility to BD based on its chromosomal localization, its predicted immunologic function as a ligand of V 1 T cells, its restricted and heat shock induced expression in epithelial cells, and a strong association of this particular MICA-TM allele, MICA-A6, with BD. In this study, to investigate whether there is the same MICA association with BD in different ethnic groups, microsatellite polymorphism in the MICA gene was analyzed in 38 Greek patients with BD and compared with that in 40 ethnically matched healthy control subjects. MATERIALS AND METHODS Subjects Patients and healthy control subjects included in this study were selected from subjects enrolled in a large ongoing case control study designed to investigate the risk factors in BD. Thirty-eight Greek patients with BD (27 men and 11 women), who fulfilled the ISG (International Study Group) diagnostic criteria for Behçet s disease 20 based on interview and clinical findings after a controlled protocol, were included, as well as 40 healthy control subjects (21 males, 19 females), unrelated to each other or to the patients and matched to the patients in ethnic origin and age 5 years. Only white people of Greek ancestry were accepted as either patients or control subjects. Patients with BD were seen as outpatients for a period of 1 year, in an outpatient rheumatology clinic in the Athens metropolitan area and were clinically examined by an experienced rheumatologist and ophthalmologist. The characteristics of the TABLE 1. BD Patient Characteristics Sex Male Female Age at onset Clinical Data Uveitis Positive 76 Oral ulcers Positive 100 Genital ulcers Positive 74 Erythema nodosum Positive 49 Vasculitis Positive 49 Arthritis of peripheral joints Positive 46 Central nervous system involvement Positive 30 Pathergy skin test Positive 38 patients with BD are presented in Table 1. The patients ages ranged from 20 to 59 years (mean, years). The age of the control subjects ranged from 19 to 68 years (mean, years). All patients and control subjects agreed to a blood examination conducted according to the guidelines of the Declaration of Helsinki. Serologic HLA Class I Typing Serologic HLA class I typing was performed using peripheral blood lymphocytes by a standard microlymphocytotoxicity technique. 21 HLA-DNA typing for the B5 group was performed in all B51 patients and control subjects by the polymerase chain reaction sequence specific oligonucleotide (PCR-SSO) method, using the unique B5 substitutions at nucleotide position 92 in exon 3. Two PCR-amplification and seven specific probes were adopted to identify the B*5101, B*5102, B*5103, and B*5104 alleles. All primers and SSOs were provided by the 12th International Histocompatibility Workshop. 22 Analysis of Triplet Repeat Polymorphism in the Transmembrane Region of the MICA Gene For analysis of microsatellite repeat polymorphism in the TM region of the MICA gene, PCR primers flanking the TM region were designed. 19 The forward primer was labeled at the 5 end with 6-FAM (PE Biosystems, Foster City, CA), and PCR was performed according to a protocol described before. 19 To determine the number of triplet repeats in the TM region of the MICA gene, the amplified products were denatured for 5 minutes at 100 C, mixed with formamide containing a stop buffer, and electrophoresed on 6% polyacrylamide gels containing 8 M urea in an automated DNA sequencer (model 373A; PE Biosystems). The number of microsatellite repeats was estimated automatically using software (Genescan 672; PE Biosystems) and the local Southern method with a size marker of 350 TAMRA (PE Biosystems) as well as the PCR products of the B-cell lines used as standard size markers that had been determined for the triplet repeat polymorphisms by nucleotidesequence determination, as described before. 19 Statistical Analysis MICA gene and phenotype frequencies were estimated by direct counting. Statistical analysis was performed by the Man- %
3 IOVS, August 1999, Vol. 40, No. 9 MICA Gene and Behçet s Disease in Greek Patients 1923 TABLE 2. Gene Frequencies of Microsatellite Polymorphism in the Transmembrane Region (Exon 5) of the MICA Gene in BD Patients and Control Subjects Microsatellite Allele Amplified Product (bp) Controls (%) (n 80) Patients (%) (n 76) OR P Pc A (17.5) 5 (6.6) A (10.0) 7 (9.2) A (27.5) 10 (13.2) A (28.8) 49 (64.5) A (16.3) 5 (6.6) tel Haenszel one-tailed and two-tailed tests. 23 The significance of the distribution of alleles between the patients with BD and normal control subjects was tested by the 2 method with the continuity correction and Fisher s exact probability test. Furthermore, P was corrected by multiplication by the number of microsatellite alleles or phenotypes (corrected P: Pc). If a cell frequency was zero, the odds ratio (OR) was calculated by first adding 0.5 to each cell frequency. 24 To control for the effect of certain factors, the Mantel Haenszel weighted OR was calculated. 23 RESULTS The gene frequencies of the microsatellite polymorphism in the TM region (exon 5) of the MICA gene are shown in Table 2. All five distinct alleles were found in the control subjects and patients with BD. The MICA-A6 allele was found at a significantly higher frequency among the patients with BD (28.8% in controls versus 64.5% in BD cases; OR 4.50; P ; Pc ). All the other alleles were found at a lower frequency (OR 1). Sixteen of the patients with BD (42.1%) and three of the control subjects (7.5%) were homozygotes for the A6 allele (OR 8.97; P ; Pc ; Table 3). The phenotype frequency of the MICA-A5 and -A6 heterozygote was relatively increased in the patients with BD, but in the other heterozygotes, carrying MICA-A6 on one chromosome was not common. Table 4 shows the phenotype frequencies of the microsatellite polymorphism in the TM region (exon 5) of the MICA gene. Of 38 patients with BD, 33 had the MICA-A6 allele in a homozygous or heterozygous way (86.8%), whereas 20 of 40 healthy control subjects had the A6 allele (50.0%). Thus, the MICA-A6 allele was found to be strongly associated with BD in this Greek sample (OR 6.60; P ; Pc ). The MICA-A6 allele was observed at a high frequency both in men (OR 5.23; P 0.015) and women (OR 11.1; P 0.020). Stratified analysis was used for the confounding effect of sex, with an OR of 6.68 (P ; Table 5). No association was found between the MICA-A6 allele and several disease features including uveitis and erythema nodosum, in which the ORs were 6.90 and 3.19, respectively, but were not statistically significant (data not shown). As is summarized in Table 6, the HLA-B*5101 allele was found in nine controls (22.5%) and in 30 BD cases (81.1%), whereas the MICA-A6 allele was found in 20 controls (50.0%) and in 33 BD cases (86.8%). Statistical analysis of these results revealed that the association of MICA-A6 with BD produced an OR of 6.60 (P ; 95% CI ), whereas B*5101 produced an OR of (P ; 95% CI 4.33 to 53.28). As expected given the location of MICA, there was a strong linkage disequilibrium between the HLA-B antigens and TABLE 3. Genotypes of Microsatellite Polymorphism in the Transmembrane Region (Exon 5) of the MICA Gene in BD Patients and Control Subjects Microsatellite Allele Controls (%) (n 40) Patients (%) (n 38) OR P Pc A4-A4 1 (2.5) 0 (0.0) A4-A5.1 2 (5.0) 0 (0.0) A4-A6 6 (15.0) 3 (7.9) A4-A9 4 (10.0) 2 (5.3) A5-A5 0 (0.0) 0 (0.0) A5-A5.1 5 (12.5) 1 (2.6) A5-A6 1 (2.5) 6 (15.8) NS A5-A9 2 (5.0) 0 (0.0) A5.1-A5.1 4 (10.0) 1 (2.6) A5.1-A6 7 (17.5) 6 (15.8) A5.1-A9 0 (0.0) 1 (2.6) A6-A6 3 (7.5) 16 (42.1) A6-A9 3 (7.5) 2 (5.3) A9-A9 2 (5.0) 0 (0.0) NS, not significant.
4 1924 Yabuki et al. IOVS, August 1999, Vol. 40, No. 9 TABLE 4. Phenotype Frequencies of Microsatellite Alleles in the Transmembrane Region (Exon 5) of the MICA Gene in BD patients and Control Subjects Microsatellite Allele Amplified Product (bp) Controls (%) (n 40) Patients (%) (n 38) OR P Pc A (32.5) 5 (13.2) A (20.0) 7 (18.4) A (45.0) 9 (23.7) A (50.0) 33 (86.8) A (27.5) 5 (13.2) the MICA microsatellite alleles in the Greek population. Notably, a strong association exists between B*5101 and MICA-A6 in both the control subjects and BD cases (weighted OR 44.39; P ; Table 7). All the 30 patients with B*5101 also possess MICA-A6. Our examinations thus far have shown that B*5101 is completely linked to MICA-A6 even in the control subjects of any ethnic origin. In comparison, MICA-A6 is linked not only to B*5101 but also to other HLA-B alleles, including B44 and B52 (data not shown). To elucidate which one is the real pathogenic gene related to BD, HLA-B*5101 or MICA-A6, an association of MICA-A6 with BD stratified for the possible confounding effect of B*5101 was analyzed. However, no association was observed in this analysis (data not shown). In contrast, when an association of B*5101 with BD stratified for the possible confounding effect of A6 was analyzed, a statistically significant association of B*5101 was observed (weighted OR 12.22; P ; 95% CI ; Table 8). DISCUSSION TABLE 5. Association of MICA-A6 and BD, Controlling for Sex MICA-A6 Male BD Female Controls BD Cases Controls BD Cases Present Absent OR P % CI Weighted OR 6.68; P ; 95% CI In this study, we have investigated microsatellite polymorphism in the TM region of the MICA gene in the Greek patients with BD. As a result, similar to the Japanese patients with BD, one particular MICA-TM allele, MICA-A6, was found to be strongly associated with BD in the Greek sample. Thirty-three of 38 patients (86.8%) were homozygous or heterozygous for MICA-A6 (Table 3), and the MICA-A6 allele was found to be distinctly predominant in the patient group. This MICA-A6 association was widely observed in the Greek patients with BD, regardless of sex and several BD clinical features. Therefore, a specific haplotype(s) surely exists in patients with BD that differs from those in healthy control subjects, and the pathogenic gene related to BD is the MICA gene itself or another gene located very near the MICA gene, including HLA-B or its nearby NOB genes. 14 In a previous study we have presented evidence that the BD pathogenic gene is located in the 230-kb segment between the MICB and HLA-C genes. 25,26 The MICA gene resides in proximity to the HLA-B gene, only 46 kb from HLA-B, and there was a strong linkage disequilibrium between them. Namely, a strong linkage between the MICA-A6 and HLA- B*5101 alleles was observed in both patients and healthy control subjects (Table 7). Thus, the HLA-B*510 MICA-A6 haplotype is predominant in the BD patient group and the pathogenic gene responsible for the predisposition to BD should be located on this haplotype. However, the MICA-A6 allele is associated with not only HLA-B51 but also HLA-B44 and -B52, which were not increased in the patient group to any degree. If MICA-A6 is primarily involved in the pathogenesis of BD, the frequencies of the HLA-B44 and -B52 antigens should be higher, along with the increase of this MICA-A6 allele. Further, stratification analysis of the MICA-A6 patients with BD on the possible confounding effect of HLA-B*5101 and vice versa (Table 8) suggests that the significant increase of MICA-A6 in the patient group could be explained by linkage disequilibrium with HLA-B*5101 and that HLA-B*5101 is a primary susceptible locus for BD. The presence of HLA- B*5101 negative patients with BD can be explained by the influence of other genetic factor(s) and/or of various external environmental or infectious agent(s). However, the possibility of the primary involvement of the MICA gene in the development of BD cannot be fully excluded. The MICA-TM (MICA-A4, -A5, -A5.1, -A6, and -A9) alleles are defined by the number of the microsatellite repeats TABLE 6. Association of BD with MICA-A6 and B*5101 Controls (%) BD Cases (%) MICA-A6* Present 20 (50.0) 33 (86.8) Absent 20 (50.0) 5 (13.2) B*5101 Present 9 (22.5) 30 (81.1) Absent 31 (77.5) 7 (8.9) *OR 6.60; P ; 95% CI OR 14.76; P ; 95% CI
5 IOVS, August 1999, Vol. 40, No. 9 MICA Gene and Behçet s Disease in Greek Patients 1925 in the TM region of the MICA gene, and MICA-A6 may not represent a unique MICA allele related to functional significance. In fact, four MICA alleles defined by genetic polymorphism in exons 2, 3, and 4, MICA003, MICA004, MICA006, and MICA009, share the same MICA-TM allele, MICA-A6, as a result of tight linkage. 27 One of these four MICA alleles sharing MICA-A6 presumably has a strong association with HLA-B51 and is possibly the real pathogenic gene for BD. In this respect, precise DNA typing in the extracellular domains (exons 2, 3, and 4) of the MICA gene is necessary and is now under investigation in our laboratory. Although V 1 T cells are of unknown function and no antigens recognized by them have been identified, they are believed to recognize self-antigens that may be stress-induced. The MICA molecule that is responsive to heat shock cell-stress was found to be recognized by V 1 T cells. Thus, two hypotheses can be set forth regarding the primary involvement of the MICA molecule with BD. First, after some bacterial infection, local immune response may be induced at the sites of infection, resulting in production of cytokines followed by stress-induced expression of MICA. Among many MICA alleles, MICA-A6 may tend to activate V 1 T cells more effectively through specific interaction with T cells, because of the presence of specific amino acids in the a1/a2 domains linked to MICA-A6 or because of a particular V 1 T-cell repertoire that can recognize MICA molecule with MICA-A6 in an efficient way, thus leading to the onset of BD. Second, after bacterial infection some bacterial components may have a specific role similar to that of superantigens in activation of the MICA molecule. In this model, a bacterial component may have specifically bound to MICA molecules with the MICA-A6 allele, induced its expression, and thus may have increased the MICA-A6 molecules that could activate V 1 T cells, triggering the unusual immune response responsible for the development of BD. In conclusion, we have investigated microsatellite polymorphism in the TM region of the MICA gene in a Greek sample and have found a strong association of a particular MICA-TM allele, MICA-A6, with BD. However, it is still uncertain which is the real pathogenic gene responsible for the development of BD, MICA-A6 or HLA-B*5101. In this respect, we have determined the genomic sequence covering the entire 1.8-Mb HLA class I region from the MICB gene to the HLA-F gene (including the MICB, MICA, HLA-B, HLA-C, HLA-E, HLA-A, HLA-G, and HLA-F genes) and have identified more than 700 microsatellite repeats in this region. It is necessary to TABLE 7. Association of MICA-A6 and B*5101, Controlling for Disease Status MICA-A6 Controls B*5101 BD Cases Present Absent Present Absent Present Absent OR P % CI Weighted OR 44.39; P TABLE 8. Association of B*5101 with BD Stratified for the Effect of MICA-A6 B*5101 analyze repeat polymorphisms at these microsatellite loci in patients with BD to determine precise localization of the pathogenic gene related to BD. Acknowledgments The authors thank Phaedon G. Kaklamanis for allowing us to use his patients and the patients who took part in this study for their cooperation. References Absence of MICA-A6 Presence of MICA-A6 Controls BD Cases Controls BD Cases Present Absent OR P NS % CI Weighted OR 12.22; P ; 95% CI NS, not significant. 1. Kaklamani VG, Vaiopoulos G, Kaklamanis PG. Behçet s disease. Semin Arthritis Rheum. 1998;27: Ohno S, Ohguchi M, Hirose S, Matsuda H, Wakisaka A, Aizawa M. Close association of HLA-Bw51 with Behçet s disease. Arch Ophthalmol. 1982;100: Mizuki N, Inoko H, Ando H, et al. Behçet s disease associated with one of the HLA-B51 subantigens, HLA-B*5101. Am J Ophthalmol. 1993;116: Mizuki N, Inoko H, Ishihara M, et al. A complete type patient with Behçet s disease associated with HLA-B*5102. Acta Ophthalmol. 1994;72: Mizuki N, Ohno S, Ando H, et al. A strong association of HLA- B*5101 with Behçet s disease in Greek patients. Tissue Antigens. 1997;50: Koumantaki Y, Stavropoulos C, Spyropoulou M, et al. HLA-B*5101 in Greek patients with Behçet s disease. Hum Immunol. 1998;59: Valente RM, Hall S, O Duffy JD, Conn DL. Vasculitis and related disorders: Behçet s disease. In: Kelly W, Harris E, Ruddy S, Sledge C, eds. Textbook of Rheumatology. Vol. 2. 5th ed., Philadelphia: Saunders; 1997: Suzuki Y, Hoshi K, Matsuda T, Mizushima Y. Increased peripheral blood T cells and natural killer cells in Behçet s disease. J Rheumatol. 1992;19: Hamzaoui K, Hamzaoui A, Hentati F, et al. Phenotype and functional profile of T cells expressing receptor from patients with active Behçet s disease. J Rheumatol. 1994;21: Esin S, Gul A, Hodara V, et al. Peripheral blood T cell expansions in patients with Behçet s disease. Clin Exp Immunol. 1997;107: Hasan A, Fortune F, Wilson A, et al. Role of T cells in pathogenesis and diagnosis of Behçet s disease. Lancet. 1996;347: Kaneko S, Suzuki N, Yamashita N, et al. Characterization of T cells specific for an epitope of human 60-kD heat shock protein (hsp) in patients with Behçet s disease (BD) in Japan. Clin Exp Immunol. 1997;108: Bahram S, Bresnahan M, Geraghty DE, Spies T. A second lineage of mammalian major histocompatibility complex class I genes. Proc Natl Acad Sci USA. 1994;91: Mizuki N, Ando H, Kimura M, et al. Nucleotide sequence analysis of the HLA class I region spanning the 237 kb segment around the HLA-B and -C genes. Genomics. 1997;42:55 66.
6 1926 Yabuki et al. IOVS, August 1999, Vol. 40, No Groh V, Bahram S, Bauer S, Herman A, Beauchamp M, Spies T. Cell stress regulated human MHC class I gene expressed in gastrointestinal epitheliums. Proc Natl Acad Sci USA. 1996;93: Bahram S, Spies T. The MIC gene family. Non-polymorphic antigen presentation molecules. Res Immunol. 1996;147: Zwirner WN, Fernandez Vina AM, Stastny P. MICA, a new polymorphic HLA-related antigen, is expressed mainly by keratinocytes, endothelial cells, and monocytes. Immunogenetics. 1998; 47: Groh V, Steinle A, Bauer S, Spies T. Recognition of stress-induced MHC molecules by intestinal epithelial T cells. Science. 1998; 279: Mizuki N, Ota M, Kimura M, et al. Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behçet s disease. Proc Natl Acad Sci USA. 1997;94: International Study Group for Behçet s Disease. Criteria for the diagnosis of Behçet s disease. Lancet. 1990;335: Terasaki PI, McCelland JD. Microdroplet assay of human serum cytotoxins. Nature. 1964;204: Ratmey MD, Tait BD. PCR-SSO typing for the B5 complex. In: Charron, D, ed. Genetic Diversity of HLA Functional and Medical Implication. Vol 1. Paris: EDK; 1997: Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1950;22: Svejgaard A, Ryder LP. HLA and disease associations: detecting the strongest association. Tissue Antigens. 1994;43: Mizuki N, Ando H, Ohno S, et al. HLA-C genotyping in the patients with Behçet s disease. Hum Immunol. 1996;50: Kimura T, Goto K, Yabuki K, et al. Microsatellite polymorphism within the MICB gene among Japanese patients with Behçet s disease. Hum Immunol. 1998;59: Fodil N, Laloux L, Wanner V, et al. Allelic repertoire of the human MHC class I MICA gene. Immunogenetics. 1996;44:
Behçet s disease (BD) is a refractory systemic inflammatory
Localization of the Pathogenic Gene of Behçet s Disease by Microsatellite Analysis of Three Different Populations Nobuhisa Mizuki, 1,2 Masao Ota, 3 Kazuro Yabuki, 1,2 Yoshihiko Katsuyama, 3 Hitoshi Ando,
More informationAssociation of MICA Polymorphism with HLA-B51 and Disease Severity in Korean Patients with Behcet's Disease
J Korean Med Sci 2002; 17: 366-70 ISSN 1011-8934 Copyright The Korean Academy of Medical Sciences Association of MICA Polymorphism with HLA-B51 and Disease Severity in Korean Patients with Behcet's Disease,
More informationA meta analysis of the association between Behçet's disease and MICA A6
BIOMEDICAL REPORTS 4: 741-745, 2016 A meta analysis of the association between Behçet's disease and MICA A6 FEIRAN WEI 1, YU ZHANG 1 and WEI LI 2 1 Clinical Medical College, Yangzhou University, Yangzhou,
More informationTitle: Lack of association of Toll-like receptor 9 gene polymorphism with
Title: Lack of association of Toll-like receptor 9 gene polymorphism with Behçet s disease in Japanese patients Short title:tlr9 gene polymorphism in Japanese patients with Behçet s disease Authors: Akiko
More informationMHC class I chain-related gene A diversity in head and neck squamous cell carcinoma
MHC class I chain-related gene A diversity in head and neck squamous cell carcinoma Judith Reinders 1, Erik Rozemuller 1, Kevin van der Ven 1, Sophie Caillat- Zucman 2, Pieter Slootweg 1, Roel de Weger
More informationSignificance of the MHC
CHAPTER 7 Major Histocompatibility Complex (MHC) What is is MHC? HLA H-2 Minor histocompatibility antigens Peter Gorer & George Sneell (1940) Significance of the MHC role in immune response role in organ
More informationMICA association with presumed ocular histoplasmosis syndrome (POHS)
Received 29 April 2003 Accepted 28 August 2003 Published 2 September 2003 MICA association with presumed ocular histoplasmosis syndrome (POHS) Judith Reinders, 1 Erik H. Rozemuller, 1 Jenny V. Ongkosuwito,
More informationHLA and antigen presentation. Department of Immunology Charles University, 2nd Medical School University Hospital Motol
HLA and antigen presentation Department of Immunology Charles University, 2nd Medical School University Hospital Motol MHC in adaptive immunity Characteristics Specificity Innate For structures shared
More informationBasic Immunology. Lecture 5 th and 6 th Recognition by MHC. Antigen presentation and MHC restriction
Basic Immunology Lecture 5 th and 6 th Recognition by MHC. Antigen presentation and MHC restriction Molecular structure of MHC, subclasses, genetics, functions. Antigen presentation and MHC restriction.
More informationHLA-B51 subtypes in Turkish patients with Behçet s disease and their correlation with clinical manifestations
HLA-B51 subtypes in Turkish patients with Behçet s disease and their correlation with clinical manifestations D.D. Demirseren 1, G.G. Ceylan 2, G. Akoglu 1, S. Emre 1, S. Erten 3, A. Arman 4 and A. Metin
More informationHLA and antigen presentation. Department of Immunology Charles University, 2nd Medical School University Hospital Motol
HLA and antigen presentation Department of Immunology Charles University, 2nd Medical School University Hospital Motol MHC in adaptive immunity Characteristics Specificity Innate For structures shared
More informationSignificance of the MHC
CHAPTER 8 Major Histocompatibility Complex (MHC) What is is MHC? HLA H-2 Minor histocompatibility antigens Peter Gorer & George Sneell (1940) Significance of the MHC role in immune response role in organ
More informationBehcet's Disease in Bahrain, Clinical and HLA Findings
Bahrain Medical Bulletin, Vol.23, No., March 200 Behcet's Disease in Bahrain, Clinical and HLA Findings Reda Ali Ebrahim, MD, FRCP* Raed Al Alawi, MD** Eman Farid, MD,PhD*** Objective: To study the clinical
More informationHuman leukocyte antigen-b27 alleles in Xinjiang Uygur patients with ankylosing spondylitis
Human leukocyte antigen-b27 alleles in Xinjiang Uygur patients with ankylosing spondylitis H.-Y. Zou, W.-Z. Yu, Z. Wang, J. He and M. Jiao Institute of Clinical Medicine, Urumqi General Hospital, Lanzhou
More informationThe major histocompatibility complex (MHC) is a group of genes that governs tumor and tissue transplantation between individuals of a species.
Immunology Dr. John J. Haddad Chapter 7 Major Histocompatibility Complex The major histocompatibility complex (MHC) is a group of genes that governs tumor and tissue transplantation between individuals
More informationMapping MHC-Encoded Susceptibility and Resistance in Primary Sclerosing Cholangitis: The Role of MICA Polymorphism
GASTROENTEROLOGY 2001;120:1475 1482 Mapping MHC-Encoded Susceptibility and Resistance in Primary Sclerosing Cholangitis: The Role of MICA Polymorphism SUZANNE NORRIS,* ELLI KONDEATIS,* ROBERT COLLINS,*
More informationAntigen Presentation to T lymphocytes
Antigen Presentation to T lymphocytes Immunology 441 Lectures 6 & 7 Chapter 6 October 10 & 12, 2016 Jessica Hamerman jhamerman@benaroyaresearch.org Office hours by arrangement Antigen processing: How are
More informationSignificance of the MHC
CHAPTER 8 Major Histocompatibility Complex (MHC) What is MHC? HLA H-2 Minor histocompatibility antigens Peter Gorer & George Sneell (1940) - MHC molecules were initially discovered during studies aimed
More informationLack of association of IL-2RA and IL-2RB polymorphisms with rheumatoid arthritis in a Han Chinese population
Lack of association of IL-2RA and IL-2RB polymorphisms with rheumatoid arthritis in a Han Chinese population J. Zhu 1 *, F. He 2 *, D.D. Zhang 2 *, J.Y. Yang 2, J. Cheng 1, R. Wu 1, B. Gong 2, X.Q. Liu
More informationGenetics and Genomics in Medicine Chapter 8 Questions
Genetics and Genomics in Medicine Chapter 8 Questions Linkage Analysis Question Question 8.1 Affected members of the pedigree above have an autosomal dominant disorder, and cytogenetic analyses using conventional
More informationThe Human Major Histocompatibility Complex
The Human Major Histocompatibility Complex 1 Location and Organization of the HLA Complex on Chromosome 6 NEJM 343(10):702-9 2 Inheritance of the HLA Complex Haplotype Inheritance (Family Study) 3 Structure
More informationADDISON S disease is the consequence of the destruction,
0021-972X/99/$03.00/0 Vol. 84, No. 10 The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright 1999 by The Endocrine Society Microsatellite Polymorphism of the MHC Class I Chain-
More informationAntigen Recognition by T cells
Antigen Recognition by T cells TCR only recognize foreign Ags displayed on cell surface These Ags can derive from pathogens, which replicate within cells or from pathogens or their products that cells
More informationHLA TYPING AND EXPRESSION: POTENTIAL MARKER FOR IDENTIFYING EARLY DYSPLASIA AND STRATIFYING THE RISK FOR IBD-CANCER
HLA TYPING AND EXPRESSION: POTENTIAL MARKER FOR IDENTIFYING EARLY DYSPLASIA AND STRATIFYING THE RISK FOR IBD-CANCER Megan Garrity, S. Breanndan Moore, M.D., William Sandborn, M.D., Vernon Pankratz, Ph.D.,
More informationHelminth worm, Schistosomiasis Trypanosomes, sleeping sickness Pneumocystis carinii. Ringworm fungus HIV Influenza
Helminth worm, Schistosomiasis Trypanosomes, sleeping sickness Pneumocystis carinii Ringworm fungus HIV Influenza Candida Staph aureus Mycobacterium tuberculosis Listeria Salmonella Streptococcus Levels
More informationInsulin Resistance. Biol 405 Molecular Medicine
Insulin Resistance Biol 405 Molecular Medicine Insulin resistance: a subnormal biological response to insulin. Defects of either insulin secretion or insulin action can cause diabetes mellitus. Insulin-dependent
More informationMHC class I MHC class II Structure of MHC antigens:
MHC class I MHC class II Structure of MHC antigens: MHC class I antigens consist of a transmembrane heavy chain (α chain) that is non-covalently associated with β2- microglobulin. Membrane proximal domain
More informationGenetic Associations of Mitochondrial DNA Polymorphisms with Behçet s Disease in a Korean Population: A Pilot Study
Journal of Rheumatic Diseases Vol. 23, No. 1, February, 2016 http://dx.doi.org/10.4078/jrd.2016.23.1.23 Original Article Genetic Associations of Mitochondrial DNA Polymorphisms with Behçet s Disease in
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Adherence, to bismuth quadruple therapy, 543 546 Adjuvant therapy, probiotics as, 567 569 Age factors, in gastric cancer, 611 612, 616 AID protein,
More informationThe Major Histocompatibility Complex
The Major Histocompatibility Complex Today we will discuss the MHC The study of MHC is necessary to understand how an immune response is generated. And these are the extra notes with respect to slides
More informationStructure and Function of Antigen Recognition Molecules
MICR2209 Structure and Function of Antigen Recognition Molecules Dr Allison Imrie allison.imrie@uwa.edu.au 1 Synopsis: In this lecture we will examine the major receptors used by cells of the innate and
More informationResearch Article The Region Centromeric to HLA-C Is a Key Region for Understanding the Phenotypic Variability of Psoriatic Arthritis
ISRN Dermatology, Article ID 570178, 5 pages http://dx.doi.org/10.1155/2014/570178 Research Article The Region Centromeric to HLA-C Is a Key Region for Understanding the Phenotypic Variability of Psoriatic
More informationthe HLA complex Hanna Mustaniemi,
the HLA complex Hanna Mustaniemi, 28.11.2007 The Major Histocompatibility Complex Major histocompatibility complex (MHC) is a gene region found in nearly all vertebrates encodes proteins with important
More informationLack of Association between Endoplasmic Reticulum Stress Response Genes and Suicidal Victims
Kobe J. Med. Sci., Vol. 53, No. 4, pp. 151-155, 2007 Lack of Association between Endoplasmic Reticulum Stress Response Genes and Suicidal Victims KAORU SAKURAI 1, NAOKI NISHIGUCHI 2, OSAMU SHIRAKAWA 2,
More informationImmunology - Lecture 2 Adaptive Immune System 1
Immunology - Lecture 2 Adaptive Immune System 1 Book chapters: Molecules of the Adaptive Immunity 6 Adaptive Cells and Organs 7 Generation of Immune Diversity Lymphocyte Antigen Receptors - 8 CD markers
More informationTCR-p-MHC 10/28/2013. Disclosures. Rheumatoid Arthritis, Psoriatic Arthritis and Autoimmunity: good genes, elegant mechanisms, bad results
Rheumatoid Arthritis, Psoriatic Arthritis and Autoimmunity: good genes, elegant mechanisms, bad results The meaning and significance of HLA associations Disclosures No relevant commercial relationships
More informationMedical Virology Immunology. Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University
Medical Virology Immunology Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University Human blood cells Phases of immune responses Microbe Naïve
More informationPolymorphims in the Interferon-y/Interleukin 26 Gene Region Contribute to Sex Bias in Susceptibility to Rheumatoid Arthritis
Polymorphims in the Interferon-y/Interleukin 26 Gene Region Contribute to Sex Bias in Susceptibility to Rheumatoid Arthritis Vandenbroeck, K., Cunningham, S., Goris, A., Alloza, I., Heggarty, S., Graham,
More information25/10/2017. Clinical Relevance of the HLA System in Blood Transfusion. Outline of talk. Major Histocompatibility Complex
Clinical Relevance of the HLA System in Blood Transfusion Dr Colin J Brown PhD FRCPath. October 2017 Outline of talk HLA genes, structure and function HLA and immune complications of transfusion TA-GVHD
More informationHLA-A*26 and Susceptibility of Iranian Patients with Non-Hodgkin Lymphoma
HLA-A*26 and Susceptibility of Iranian Patients with Non-Hodgkin Lymphoma Arezou Sayad 1, Mohammad Taghi Akbari 2**, Mahshid Mehdizadeh 3,4, Mohammad Taheri 1, Abbas Hajifathali 3* 1 Department of Medical
More informationThe MHC and Transplantation Brendan Clark. Transplant Immunology, St James s University Hospital, Leeds, UK
The MHC and Transplantation Brendan Clark Transplant Immunology, St James s University Hospital, Leeds, UK Blood Groups Immunofluorescent staining has revealed blood group substance in the cell membranes
More informationPhase of immune response
Antigen and antigen recognition by lymphocytes Antigen presentation to T lymphocytes Sanipa Suradhat Department of Veterinary Microbiology Faculty of Veterinary Science Phase of immune response 1 Phase
More informationHOST-PARASITE INTERPLAY
HOST-PARASITE INTERPLAY Adriano Casulli EURLP, ISS (Rome, Italy) HOST-PARASITE INTERPLAY WP3 (parasite virulence vs human immunity) (Parasite) Task 3.1: Genotypic characterization Task 3.6: Transcriptome
More informationHLA and more. Ilias I.N. Doxiadis. Geneva 03/04/2012.
www.ebmt.org HLA and more Ilias I.N. Doxiadis Geneva 03/04/2012 HLA and more HLA and more / Doxiadis 2 Topic of the day Compatibility testing is a type of testing used to ensure compatibility of the system/application/website
More informationSUPPLEMENTARY INFORMATION. Divergent TLR7/9 signaling and type I interferon production distinguish
SUPPLEMENTARY INFOATION Divergent TLR7/9 signaling and type I interferon production distinguish pathogenic and non-pathogenic AIDS-virus infections Judith N. Mandl, Ashley P. Barry, Thomas H. Vanderford,
More informationEarly onset of polyglandular failure is associated with HLA-DRB1*03
European Journal of Endocrinology (2008) 159 55 60 ISSN 0804-4643 CLINICAL STUDY Early onset of polyglandular failure is associated with HLA-DRB1*03 Manuela Dittmar 1,2, Maximilian Ide 1, Michael Wurm
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/49010 holds various files of this Leiden University dissertation. Author: Heide, A. van der Title: Unravelling narcolepsy : from pathophysiology to measuring
More informationHuman leukocyte antigen (HLA) system
Is HLA a determinant of prognosis or therapeutic response to cytokines, IFN and anti-ctla4 blocking antibodies in melanoma? Helen Gogas, M.D. Ass. Professor in Medical Oncology 1st Department of Medicine,
More informationMajor Histocompatibility Complex (MHC) and T Cell Receptors
Major Histocompatibility Complex (MHC) and T Cell Receptors Historical Background Genes in the MHC were first identified as being important genes in rejection of transplanted tissues Genes within the MHC
More informationMHC class I chain related gene A (MICA) modulates the development of coeliac disease in patients with the high risk heterodimer DQA1*0501/DQB1*0201
336 COELIAC DISEASE MHC class I chain related gene A (MICA) modulates the development of coeliac disease in patients with the high risk heterodimer DQA1*0501/DQB1*0201 A Lopez-Vazquez, L Rodrigo, D Fuentes,
More informationThe Major Histocompatibility Complex (MHC)
The Major Histocompatibility Complex (MHC) An introduction to adaptive immune system before we discuss MHC B cells The main cells of adaptive immune system are: -B cells -T cells B cells: Recognize antigens
More informationASSESSMENT OF THE RISK FOR TYPE 1 DIABETES MELLITUS CONFERRED BY HLA CLASS II GENES. Irina Durbală
ASSESSMENT OF THE RISK FOR TYPE 1 DIABETES MELLITUS CONFERRED BY HLA CLASS II GENES Summary Irina Durbală CELL AND MOLECULAR BIOLOGY DEPARTMENT FACULTY OF MEDICINE, OVIDIUS UNIVERSITY CONSTANŢA Class II
More informationToll-like Receptors (TLRs): Biology, Pathology and Therapeutics
Toll-like Receptors (TLRs): Biology, Pathology and Therapeutics Dr Sarah Sasson SydPATH Registrar 23 rd June 2014 TLRs: Introduction Discovered in 1990s Recognise conserved structures in pathogens Rely
More informationIMMUNE CELL SURFACE RECEPTORS AND THEIR FUNCTIONS
LECTURE: 07 Title: IMMUNE CELL SURFACE RECEPTORS AND THEIR FUNCTIONS LEARNING OBJECTIVES: The student should be able to: The chemical nature of the cellular surface receptors. Define the location of the
More informationAllele and Haplotype Frequencies of Human Leukocyte Antigen-A, -B, -C, -DRB1, and -DQB1 From Sequence- Based DNA Typing Data in Koreans
Original Article Diagnostic Immunology Ann Lab Med 2015;35:429-435 http://dx.doi.org/10.3343/alm.2015.35.4.429 ISSN 2234-3806 eissn 2234-3814 Allele and Haplotype Frequencies of Human Leukocyte Antigen-A,
More informationScientometric analysis and mapping of scientific articles on Behcet s disease
International Journal of Rheumatic Diseases 2013; 16: 185 192 ORIGINAL ARTICLE Scientometric analysis and mapping of scientific articles on Behcet s disease Farhad SHAHRAM, 1 Ahmad-Reza JAMSHIDI, 1 Armin
More informationANALYSIS OF IL17 AND IL17RA POLYMORPHISMS IN SPANISH PSORIASIS PATIENTS: ASSOCIATION WITH RISK FOR DISEASE.
ANALYSIS OF IL17 AND IL17RA POLYMORPHISMS IN SPANISH PSORIASIS PATIENTS: ASSOCIATION WITH RISK FOR DISEASE. Batalla A, Coto E*, González-Lara L, González- Fernández D, Maldonado-Seral C, García-García
More informationProfiling HLA motifs by large scale peptide sequencing Agilent Innovators Tour David K. Crockett ARUP Laboratories February 10, 2009
Profiling HLA motifs by large scale peptide sequencing 2009 Agilent Innovators Tour David K. Crockett ARUP Laboratories February 10, 2009 HLA Background The human leukocyte antigen system (HLA) is the
More informationIT IS WELL known that type 1 diabetes mellitus (T1DM) is
0013-7227/01/$03.00/0 The Journal of Clinical Endocrinology & Metabolism 86(8):3754 3760 Printed in U.S.A. Copyright 2001 by The Endocrine Society Two Distinct MICA Gene Markers Discriminate Major Autoimmune
More informationFONS Nové sekvenační technologie vklinickédiagnostice?
FONS 2010 Nové sekvenační technologie vklinickédiagnostice? Sekvenování amplikonů Sequence capture Celogenomové sekvenování FONS 2010 Sekvenování amplikonů Amplicon sequencing - amplicon sequencing enables
More informationCellular Pathology of immunological disorders
Cellular Pathology of immunological disorders SCBM344 Cellular and Molecular Pathology Witchuda Payuhakrit, Ph.D (Pathobiology) witchuda.pay@mahidol.ac.th Objectives Describe the etiology of immunological
More informationLESSON 2: THE ADAPTIVE IMMUNITY
Introduction to immunology. LESSON 2: THE ADAPTIVE IMMUNITY Today we will get to know: The adaptive immunity T- and B-cells Antigens and their recognition How T-cells work 1 The adaptive immunity Unlike
More informationIMMUNOGENETICS AND TRANSPLANTATION
IMMUNOGENETICS AND TRANSPLANTATION WHAT S THE MHC GOT TO DO WITH TRANSPLANTATION? We have learned that the molecules of Class I and II MHC are involved in presenting antigenic peptides to the receptors
More informationRobert B. Colvin, M.D. Department of Pathology Massachusetts General Hospital Harvard Medical School
Harvard-MIT Division of Health Sciences and Technology HST.035: Principle and Practice of Human Pathology Dr. Robert B. Colvin Transplantation: Friendly organs in a hostile environment Robert B. Colvin,
More informationPolymorphism of the PAI-1gene (4G/5G) may be linked with Polycystic Ovary Syndrome and associated pregnancy disorders in South Indian Women
www.bioinformation.net Volume 13(5) Hypothesis Polymorphism of the PAI-1gene (4G/5G) may be linked with Polycystic Ovary Syndrome and associated pregnancy disorders in South Indian Women Maniraja Jesintha
More informationImmunology. T-Lymphocytes. 16. Oktober 2014, Ruhr-Universität Bochum Karin Peters,
Immunology T-Lymphocytes 16. Oktober 2014, Ruhr-Universität Bochum Karin Peters, karin.peters@rub.de The role of T-effector cells in the immune response against microbes cellular immunity humoral immunity
More informationJ Jpn Coll Angiol, 2009, 49: collagen disease, genetic polymorphism, MRL mice, recombinant inbred strains, Cd72. MRL/Mp-lpr/lpr MRL/ lpr
Online publication June 24, 2009 1, 2 1 J Jpn Coll Angiol, 2009, 49: 11 16 collagen disease, genetic polymorphism, MRL mice, recombinant inbred strains, Cd72 SNPs case-control study MHC Fcγ NO MRL/Mp-lpr/lpr
More informationAssociation of MHC Class I chain-related A (MIC-A) gene polymorphism with Type I diabetes
Diabetologia (2000) 43: 507±514 Ó Springer-Verlag 2000 Association of MHC Class I chain-related A (MIC-A) gene polymorphism with Type I diabetes G. Gambelunghe 1, M. Ghaderi 1, A. Cosentino 2, Ad. Falorni
More informationMRC-Holland MLPA. Description version 07; 26 November 2015
SALSA MLPA probemix P266-B1 CLCNKB Lot B1-0415, B1-0911. As compared to version A1 (lot A1-0908), one target probe for CLCNKB (exon 11) has been replaced. In addition, one reference probe has been replaced
More informationTopic (Final-03): Immunologic Tolerance and Autoimmunity-Part II
Topic (Final-03): Immunologic Tolerance and Autoimmunity-Part II MECHANISMS OF AUTOIMMUNITY The possibility that an individual s immune system may react against autologous antigens and cause tissue injury
More informationRetrospective Genetic Analysis of Efficacy and Adverse Events in a Rheumatoid Arthritis Population Treated with Methotrexate and Anti-TNF-α
Retrospective Genetic Analysis of Efficacy and Adverse Events in a Rheumatoid Arthritis Population Treated with Methotrexate and Anti-TNF-α Foti A 1, Lichter D 1, Shadick NA 2, Maher NE 2, Ginsburg GS
More informationClinical Relevance of the HLA System in Blood Transfusion. Dr Colin J Brown PhD FRCPath. October 2017
Clinical Relevance of the HLA System in Blood Transfusion Dr Colin J Brown PhD FRCPath. October 2017 Outline of talk HLA genes, structure and function HLA and immune complications of transfusion TA-GVHD
More informationAssociation of IL1R polymorphism with HLA-B27 positive in Iranian patients with ankylosing spondylitis
Eur. Cytokine Netw. Vol. 22 n 4, December 2011, 175-80 175 RESEARCH ARTICLE Association of IL1R polymorphism with HLA-B27 positive in Iranian patients with ankylosing spondylitis M. Mahmoudi 1,2, A.A.
More informationMinimal Requirements for Histocompatibility & Immunogenetics Laboratory
Minimal Requirements for Histocompatibility & Immunogenetics Laboratory The 4 th WBMT Congress and Workshop Riyadh, KSA - January 15-17, 2017 HLA Discovery, 1958 The Nobel Prize in Physiology or Medicine
More informationImmunogenetics of Episcleritis in Leprosy
Immunogenetics of Episcleritis in Leprosy Satoru Joko, * Jiro Numaga, * Yujiro Fujino, * S. M. M. Islam, * Kanjiro Masuda * and Hiroo Maeda * Department of Ophthalmology, University of Tokyo School of
More informationThe Major Histocompatibility Complex of Genes
The Major Histocompatibility Complex of Genes Topic 4 The Major Histocompatibility Complex Outline of Lectures The immunological reasons for transplant rejection How the MHC was discovered using inbred
More informationHUMAN LEUCOCYTE ANTIGEN (HLA) CLASS I AND II FREQUENCIES IN SELECTED GROUPS IN LEBANON
Journal Scientifique Libanais, Vol. 1, No. 1, 2000 119 HUMAN LEUCOCYTE ANTIGEN (HLA) CLASS I AND II FREQUENCIES IN SELECTED GROUPS IN LEBANON Alexander M. Abdelnoor, May Abdelnoor, Walid Heneine, Firas
More informationThe Innate Immune Response
The Innate Immune Response FUNCTIONS OF THE IMMUNE SYSTEM: Recognize, destroy and clear a diversity of pathogens. Initiate tissue and wound healing processes. Recognize and clear damaged self components.
More informationCompleting the CIBMTR Confirmation of HLA Typing Form (Form 2005)
Completing the CIBMTR Confirmation of HLA Typing Form (Form 2005) Stephen Spellman Research Manager NMDP Scientific Services Maria Brown Scientific Services Specialist Data Management Conference 2007 1
More informationRequirements in the Development of an Autoimmune Disease Amino Acids in the Shared Epitope
+ T cell MHC/self-peptide MHC/Vβ Induction of + T H 1 mediated autoimmunity: A paradigm for the pathogenesis of rheumatoid arthritis, multiple sclerosis and type I diabetes APC Activated autoreactive +
More informationHost-parasite interactions: Evolutionary genetics of the House Finch- Mycoplasma epizootic
Host-parasite interactions: Evolutionary genetics of the House Finch- Mycoplasma epizootic Scott V. Edwards Department of Organismic and Evolutionary Biology Harvard University Cambridge, MA USA http://www.oeb.harvard.edu/faculty/edwards
More informationHLA Complex Genetics & Biology
HLA Complex Genetics & Biology M. Tevfik DORAK Environmental & Occupational Health College of Public Health Florida International University Miami, USA http://www.dorak.info Mount Sinai Medical Center
More informationChapter 6. Antigen Presentation to T lymphocytes
Chapter 6 Antigen Presentation to T lymphocytes Generation of T-cell Receptor Ligands T cells only recognize Ags displayed on cell surfaces These Ags may be derived from pathogens that replicate within
More informationOutline. How archaics shaped the modern immune system. The immune system. Innate immune system. Adaptive immune system
Outline How archaics shaped the modern immune system Alan R. Rogers February 14, 2018 Why the immune system is sensitive to archaic introgression. Archaic MHC alleles The OAS1 innate immunity locus 1 /
More informationTitle: NATURAL KILLER CELL FUNCTIONS AND SURFACE RECEPTORS
LECTURE: 14 Title: NATURAL KILLER CELL FUNCTIONS AND SURFACE RECEPTORS LEARNING OBJECTIVES: The student should be able to: Describe the general morphology of the NK-cells. Enumerate the different functions
More informationHLA-DR2 and IKBL+738(C) in Dutch Ulcerative Colitis Patients
HLA-DR2 and IKBL+738(C) in Dutch Ulcerative Colitis Patients Boukje de Vries Student from the VUmc Amsterdam The Netherlands September 2002 January 2003 Supervisors: EG de la Concha, AS Peña, L Fernandez
More informationDistribution of HLA Antigens Class I and II in Iraqi Arab population
Distribution of HLA s Class I and II in Iraqi Arab population *Ahmed A.A. Al-Hassan, MSc, Immunology ; **Sana a Al-Naseri, MD, ph.d, immunopathology *** Batool H. Al-Ghurabi, ph.d, Immunology **** Mohammed
More informationCytokines (II) Dr. Aws Alshamsan Department of Pharmaceu5cs Office: AA87 Tel:
Cytokines (II) Dr. Aws Alshamsan Department of Pharmaceu5cs Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa Learning Objectives By the end of this lecture you will be able to: 1 Understand the physiological
More informationHLA and disease association
J Headache Pain (2000) 1:S109 S113 Springer-Verlag 2000 Simonetta Trabace HLA and disease association S. Trabace ( ) Section of Medical Genetics, Department of Experimental Medicine and Pathology, Department
More informationAUTOIMMUNITY CLINICAL CORRELATES
AUTOIMMUNITY CLINICAL CORRELATES Pamela E. Prete, MD, FACP, FACR Section Chief, Rheumatology VA Healthcare System, Long Beach, CA Professor of Medicine, Emeritus University of California, Irvine Colonel
More informationAUTOIMMUNITY TOLERANCE TO SELF
AUTOIMMUNITY CLINICAL CORRELATES Pamela E. Prete, MD, FACP, FACR Section Chief, Rheumatology VA Healthcare System, Long Beach, CA Professor of Medicine, Emeritus University of California, Irvine Colonel
More informationChapter 22: The Lymphatic System and Immunity
Bio40C schedule Lecture Immune system Lab Quiz 2 this week; bring a scantron! Study guide on my website (see lab assignments) Extra credit Critical thinking questions at end of chapters 5 pts/chapter Due
More informationDefinition of MHC supertypes through clustering of MHC peptide binding repertoires
Definition of MHC supertypes through clustering of MHC peptide binding repertoires Pedro A. Reche and Ellis L. Reinherz Laboratory of Immunobiology and Department of Medical Oncology, Dana-Farber Cancer
More informationTransplantation. Immunology Unit College of Medicine King Saud University
Transplantation Immunology Unit College of Medicine King Saud University Objectives To understand the diversity among human leukocyte antigens (HLA) or major histocompatibility complex (MHC) To know the
More informationIVF Michigan, Rochester Hills, Michigan, and Reproductive Genetics Institute, Chicago, Illinois
FERTILITY AND STERILITY VOL. 80, NO. 4, OCTOBER 2003 Copyright 2003 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. CASE REPORTS Preimplantation
More information2017 EFI/DGI Meeting Teaching Session I
2017 EFI/DGI Meeting Teaching Session I Mannheim, Wednesday, 31.05.2017 10:30 12:00 Role of non-classical HLA in Stem Cell Transplantation 10:30 10:40 Non Classical HLA-Molecules J. Mytilineos, Ulm 10:40
More informationHandling Immunogenetic Data Managing and Validating HLA Data
Handling Immunogenetic Data Managing and Validating HLA Data Steven J. Mack PhD Children s Hospital Oakland Research Institute 16 th IHIW & Joint Conference Sunday 3 June, 2012 Overview 1. Master Analytical
More informationImmune System AP SBI4UP
Immune System AP SBI4UP TYPES OF IMMUNITY INNATE IMMUNITY ACQUIRED IMMUNITY EXTERNAL DEFENCES INTERNAL DEFENCES HUMORAL RESPONSE Skin Phagocytic Cells CELL- MEDIATED RESPONSE Mucus layer Antimicrobial
More informationDEFINITIONS OF HISTOCOMPATIBILITY TYPING TERMS
DEFINITIONS OF HISTOCOMPATIBILITY TYPING TERMS The definitions below are intended as general concepts. There will be exceptions to these general definitions. These definitions do not imply any specific
More informationRelationship Between HLA-DMA, DMB Alleles and Type 1 Diabetes in Chinese
HK J Paediatr (new series) 2005;10:20-25 Relationship Between HLA-DMA, DMB Alleles and Type 1 Diabetes in Chinese YM SANG, C YAN, C ZHU, GC NI, YM HU Abstract Key words The Human Leucocyte Antigen (HLA)-DMA
More information